Healthcare -
Biotechnology - NYSE - DK
$ 78.69
-5.27 %
$ 349 B
Market Cap
26.86
P/E
NVO - DEPRECIATION & AMORTIZATION
Depreciation & Amortization NVO - Novo Nordisk A/S
9.41 B
LAST VALUE
24.99%
2 YEAR CAGR
19.12%
5 YEAR CAGR
12.89%
10 YEAR CAGR